ChemoCentryx: Analyst Day (Chemocentryx) - May 29, 2013 - "P2, N=159"; "Gateway to Diabetic Nephropathy - Successful Phase II Proof of Concept Trial in Type 2 Diabetics Inhibiting CCR2 with CCX140"; "CCX140 Decreases Fasting Plasma Glucose"
P2 data • Diabetes • Renal Disease
|